Walking patients treated for disabling spasticity
Dr Sihem Neila ABTROUN-AKKOUCHEa, Prof Saliha AKDADER-MAHIOUa, Prof Mohamed RACHEDIb, Dr Ferroudja IGGUIc, Prof Ziania DJAROUDd, Prof Mohamed BENMANSOURe, Dr Mourad ADERKICHIf, Dr Soumaya LEMAIg, Prof Ahmed AHRASa
a Etablissement Hospitalier Spécialisé Ben Aknoun Alger, b HMUS Alger, c Hopital Médéa, d EHU Oran, e CHU Tlemcen, f CHU Tizi ouzou, g CHU Constantine
Objective: Analysis of the management of walking adult patients with disabling spasticity in Algeria.
Method: In 2014 a multicenter survey has been conducted through 7 PRM centers in north Algeria; 450 adult patients treated for disabling spasticity have been identified. We report a post-hoc subgroup analysis of 259 walking patients.
Results: n=259. Mean age = 46,2 years. The most frequent etiology was post stroke hemiplegia. The patient’s grievance was function (65,63%) and comfort (57,91%). The treatments received were physiotherapy (81,85%) botulinum toxin injections (67,18%)and oral medication (40,92%). Botulinum toxin therapy targeted the soleus, the gastrocnemius and the adductor muscles.
Discussion: The identified population is young, the Botulinum toxin therapy has been used in 2/3 of the patients but the targeted muscles were not consistent with the literature. This analysis of our practice will let us improve and unify our management of spasticty.
Keywords : Spasticity, Locomotion